ONLINE SUBMISSION
  February, 2000

Gender and Schizophrenia

  M. Afzal Javed  ( University of Warwick, The Medical Centre 2. Manor Court Avenue. Nttneaton CVII5HX, United Kingdom. )
 


Schizophrenia is one of the most serious mental illnesses with about I in 100 people developing the disorder over a lifetime. This illness can begin at any age but commonly manifests itself in the late teens through early to mid 20’s. It is prevalent in both sexes and the clinicians are now accepting that outcome of schizophrenia is multi­dimensional across interlinked domains of symptoms severity, social/functional disability, employment and a number of treatment and management variables1.
Although, many modern approaches to diagnose and describe the phenomenology of this illness have been proposed since the original description by Kraepelin2, controversy still exists regarding the nosological boundaries of schizophrenia and related disorders. Described at times as one distinct syndrome it is now generally considered a group o syndromes which are phenomenologically heterogeneous.
The difference of opinion varies across a number of parameters ranging from aetiology to treattnent, causes to manifestations and sensitivity to response to different management strategies. When it comes to the issues of gender, schizophrenia plays a decidedly different role, not only does it strike men and women at different ages but it follows different course and displays a remarkable gender sensitivity to treatment.
Age at Onset
Schizophrenia has a later onset in females than in males and this difference has been found to be about 5 years in most studies. Considering all measures of onset into account, like earliest sign of mental disorder, first psychotic symptoms and hospitalisation, it is suggested that women, as a group, have a significantly later age of onset. The peak age of onset in males is from 21-25 years whereas in females the peak age of onset is from 25-32 years3.
The difference in age at onset is also consistent across a number of studies carried out in difference cultures. A multi-cultural WHO collaborative study confirmed that age of onset was lower in male schizophrenics in different centres4. ln an another study of 392 consecutive first admissions from a defined catchment area with a diagnosis oF schizophrenia or paranoid disorder, males showed a single peak in their early 20’s while females had an onset at a later age group5. Similarly results were reported by others6,7.
Life events precipitating the onset seem to be more commonly reported by women. Schizophrenic women show a significant seasonality of first admissions as compared to the males and season of onset also differs among the different sexes8,9.
Phenomenology
Differences exist in the symptoms of schizophrenia between either sexes10-12. Overall, women with schizophrenia appear to have a less severe clinical presentation and clinical course. A number of studies and reviews have éoncluded that male patients are generally prone to express more negative symptoms as well as social withdrawal and blunted or incongruent effects than female patients. Women schizophrenics on the other hand, are more likely to present with mood disturbances, dysphoria, depressive symptoms and atypical affective features. Substance abuse and anti-social behaviours have also been found to be more common in schizophrenic men, than the women12,13. The complexity of the association and overlap between schizophrenia and affective disorders in female schizophrenics are also interesting. Recent reviews suggest that females with schizophrenia are more likely to receive differential diagnosis of affective, atypical or manic psychosis and are over-represented among patients with a diagnosis sch izoaffective d isordér. Furthermore, women appear to be more susceptible to acute reactive psychosis and schizophrenform disorders which present as florid and abrupt onset psychotic states and tend to resolve with good outcome. A study from India published the results of long term course of psychosis and found a better outcome in women than men14.
Ring et al15 also found that men and women were not effected equally by schizophrenia. In their study, negative symptoms such as affective flattening, poverty of’ speech and social withdrawal were more prevalent among males than females both in extent as well as severity.
Pit-Morbid Functions
Abnormalities in pit-morbid functioning particularly in intellectual and social areas have been well documented in schizophrenia. A range of studies and reports are now available which suggest that the pre-morbid deficits are more common and more severe in boys than girls who later on develop schizophrenia16,17. Retrospective reports and follow-up of children presenting to ‘mental health services and of those at high risk suggest similar results. The presence of such deficits also predict an early onset of schizophrenic psychopathology, in male gender.
Developmental Phase and Gender
The neurodevelopmental model of schizophrenia is strongly supported by ‘evidence that persons, who later develop this disorder, have abnonnal developments in early years. Crow et al18 confirmed this view, point and suggested that developmental abnormalities prior to the onset of psychosis differ by gender. Boys who will later develop schizophrenia tend to be irritable, disagreeable and defiant of authority. In contrast girls are insecure, shy and participate less in groups.
Genetic Vulnerability
There is a convincing evidence about the familiar predisposition and genetic vulnerability to develop schizophrenic illnesses and reports confirm about different models of genetic risks operating at different levels. Although, no specific studies are available about different genetic predisposition to schizophrenia for males and females, there has been some interest to find out whether the families of schizophrenic men and women are at different degrees of moderate risk for this disorder.
Goldstein et al19 re-analysed the data from the IOWA cohort of schizophrenic patients for whom family interview diagnostic data was obtained. Age corrected life time risk of DSM Ill schizoprhenia, in the first degree relatives of schizophrenic men was 2.2% as compared to 5.2% in relatives of schizophrenic women. This notion also got support from some other work which predicted that relatives of male and female patients seem to be at different risk20. Interestingly, increased risk to the relatives is ‘found in some other disorders such as stuttering and epilepsy and if these findings are to be linked to the curtent aetiological model of schizophrenia being considered as a neuro developmental disorder, such findings can thus have an important and long lasting impact in understanding of this disorder
Oestrogen Hypothesis
Evidence demonstrating modulating effects of oestrogen on the symptoms of schizophrenia provides basis for an association in this regard. Strong support for this hypothesis comes From various findings21-23. Variations in the severity of symptoms are found as oestrogen level changes during the menstrual cycle, relapse rate of women with pre-existing schizophrenia is reduced during pregnancy and mental state changes that occur around the time of menopause are related to this hormone.
Brain Structure and Morphological Changes
As sex differences in normal brain functioning and morphology have long been known to exist, there has been some reports to suggest similar differences in the brains of male and female schizophrenic patients24. Castle and Murray25 reviewed the findings in this area and concluded that there is an evidence for this difference. Studies using MRI have also shown reduced coronal brain area, small left hippocampal formation and enlarged lateral ventricles in men with schizophrenia. but not in women26-28, Magnetic resonance imaging (MRI) studies also suggest that many of the structural brain abnormalities in schizophrenia occur in ‘areas that are normally sexually dimorphic26. Compared to men, women have a greater ratio of grey matter in the caudate, hypocampus, frontal cortex and temporal gyrus- all of which are involved in higher functions including language, thinking, sustained attention and working memory. These results may suggest that normal sexual dimorphism may help to protect schizophrenic women from some of the more severe cognitive consequences of brain abnormalities associated with the disorder.
Johnston et al27 re-analysed the post-morten data on schizophrenic patients in terms of gender differences and found that brains of female patients showed more gliosis and focal damage than males. This work indeed raised the question whether such features represent any specific gender vulnerability, in this disorder.
The association between prenatal exposure to influenza and later onset of schizophrenia is well documented. Regarding the gender differences examined in seven studies, five showed that the effect reached significance only for females28. Re-analysis of Kendel and Kemp’s data29 also showed an effect for females, but not males30. Similarly Takei et at31 while looking at influenza epidemics over a long time period, demonstrated the significance of this causative factor more in female than male schizophrenics.
Culture and Gender Difference
World Health Organ isation conducted a systematic research on the influence of gender factors on age at onset, symptomatology and course of schizophrenia in seven research centres of three different cultures. It was revealed that females did have an early onset and had more non­specific symptoms like irritability and tiredness than males. Males on the other hand reported to have more maladaptive behaviour like alcohol abuse and social wiffidrawa”.
Treatment
Many reports strongly suggest that treatment response is faster in women, the duration of psychosis is reduced and the amount of anti-psychotic drugs used even on a milligram per kilogram basis is significantly lower in female schizophenics32,33. Szymanski et al3, while using the standard doses of anti-psychotic drugs in men and women admitted to hospital with a first episode of schizophrenia, found more rapid and complete remission for women. Overall 95% of women attained full remission from their first episode, compared to 70% for men. Also, differentiating on the basis of the sexes, the response to psychosocial interventions was variable. Studies are also showing that unlike men, women who have intensive ‘family intervention in conjunction with psychophannacological treatment continue to iniprove significantly after discharge from hospital as compared to the male schizophrenics34.
Course and Outcome
Schizophrenia runs a chronic course. Although, there has been a nuniber of developments in area of treatment, management and rehabilitation, the overall outlook of schizophrenia is not very promising. If we consider the course and outcome of this illness with a special reference to gender the results are again suggestive of a difference between two sexes. Studies carried out during the past few decades are consistent in showing the difference between the sexes and reflect a need to consider this variable more im portantly35,36.
Angermeyer37, reviewed the whole literature on the effects of gender on the course of schizophrenia. Out of 102 published studies in this area the findings showed some consensus. Regardless of the precise outcome measures used, either clinical, time spent in hospital, number of relapses, symptoms at follow-up like social functioning, social adaptation or occupational status, more than half of these studies showed statistically significant difference in terms of gender. The conclusion was that the outcome of schizophrenia is better in women at various lengths of follow-up. Men were at greater risk of re-admissions and they spent almost twice as long in hospital as the women.
Part of the outcome studies also showed better pre­morbid social adjustments of females and long term outcomes were found to be better than males in terms of social activity, work competence, substance abuse and marital and parental status. Thara et al38 followed ninety, first episode patients fulfilling lCD 9 criteria for schizophrenia prospectively for 10 years. They found that factors like phenomenology and duration of illness were very significant in the outcome of this illness. But being male and presence of self’ neglect, religious delusions and hallucinations predicted poorer pattern of the illness.
In terms of treatment there were strong indications of better drug response in females and also of their less liability to develop long term effects of neuroleptic treatment. Reports also showed that significantly more women were married than the men at the follow up and had less disability in social functioning39. Similarly female schizophrenic patients were enjoying a better quality of life than male patients %vhen assessed on different aspects of functioning and quality of life40.
Negative Findings
Despite a number of studies showing the gender difference in Schizophrenia, there are some reports which call into question the universality of such differences.
Murthy et al41 were unable to find an early age of onset in male schizophrenics. Survival analysis of subjects in their study, in fact, documented a female preponderance at younger age. Shankar et al42 indicated that females were more disabled than males and there were no differences between the sexes either on mean age or duration of illness.
Lindstrom and Kn orring43 from Sweden correlated syndromes of sch izophren i a (positive, negative, excited, anxious/depressive and cognitive factors) with background factors but could not find any significance to age or sex differences. Fenning et al44 looked at gender premorbid characteristics and negative symptoms in schizophrenia. Their findings supported the importance of assessing negative symptoms longitudinally but suggested that gender is not strongly associated with these symptoms profile.
Kendler and Walsh in their epidemiologically based study in Ireland45 were unable to show any demonstrable impact of gender on the presentation and course of schizophrenia. Contrary to other reports, no evidence was found in their study that schizophrenia in women, compared to men, is more closely related to affective illness from a symptomatic or fain ilial perspective.


Conclusion

The evidence provided on The whole in this paper generally points towards a different susceptibility of males and females for schizophrenia. Despite few studies to the contrary most of the work consistently show that schizophrenic males as compared to female patients are more likely to have early onset, present with frequent negative symptoms and severe symtomatology and show more structural brain abnormalities and relatively less promising response to neuroleptic medication. The dissimilarities in terms of gender are also evident in, pre­morbid functioning, social demographic Attributes and the overall course and prognosis of this illness. It is true that the differences in expression of this disorder between men and women have long been ignored. but such differences are appearing more significantly and being addressed more precisely in current studies. Along with some genetic vulnerability and other environmental factors it thus may be the case that we are in fact having two types of schizophrenias, one male schizophrenia and the other female schizophrenia, (Figure 1)

or we may he dealing with one disorder with overlapping of these two distinct syndromes, but retaining the individual characteristics (Figure 2).

The second Option, however, looks more promising and viable.
In present day classifications, we prefer sub-typing of schizophrenia as it is argued that this illness comprises of a group of syndromes. The advantage of using gender as the sub-dividing variable by which to look For heterogeneity of this disorder, will therefore be conipletelv reliable and valid in many ways. Apart from getting a number of advantages by grouping schizophrenia by gender, we may be able to get some more insight to the understanding of this illness. Schizophrenia is currently being explained by a number of psycho-sociôbiological factors, the observable gender sensitivity in terms of aetio logy presentation, psychopathology and response to the treatment will therefore be of much help in this regard. Such findings will also have implications for treatment and rehabilitation in this illness. Perhaps there may be some hope in certain areas of cognition where we may focus more on women and perhaps there will be the development of some sex specific medication that will alter neurotransmissions differently in different genders.
It is hoped that as these differences get more clarity the understanding of this disorder will become more fascinating, informative, as well as, insightful. It is therefore the appropriate time that physicians should become more aware that schizophrenia, as they know, is difierent in males and females and that several findings should he taken as further fines of guidance. OF course the observed neurobioliogical and psychosocial difference require further explorations. Such differences will also require more critical reviews specially in terms of offering different psychosocial interventions and pharmacological treatments in different gender. But, as sex differences in schizophrenia become better documented, their importance to the understanding of the disorder itself will become clearer. This topic will hopefully assume a paramount importance in future research in schizophrenia and we will enter the next century with more clarification of many concepts which are still unclear and ucertain.


Acknowledgements

The author is thankful to Prof. Chaudhry, Prof. Tarren and Dr. Quasint for their valuable comments on this paper. Tracey Rylance\'s untiring efforts to type different drafts are also highly acknowledged.


References

1.iabieasky A. the epidemiology of Schizophrenia. Current opinion in Psychiatry, 1993 ;6 :43-52.
2.Kraepelin E, Psychiatric Em Lehrbueh Eni Stndicrcnde lind Ante (6th cd) Leipzig: J.A. Bank, 1899.
3.Szymanski S. Lieberman JA, Alvir JM. et at, Gender diiThrenccs in onset of illness, treatment response. course and biological indenes in first episode schizophrenic paticnts. Amer. J. Psychiat.. 1995:152:698-703.
4,Hamhrecht M, Maurer HK, Hafncr Ii. Gender differences in schizophrenia in three cultures. Results of the W HO eollaborative study an psychiatric disability. Social Psychiatry and Psychiatric Epidemiology. 1992:27:117-21.
5.Hafner H, Behrens S. de Vry J, et al. Implications for sex difference in Schizophrenia. Psychiatry Research, 1991:38:125-34.
6.Flafner H, Maurer K. Loflier W. et at. The influence of age and sex on the onset and early course of Schizophrenia. Br. J. Psychiat.. 1993:162:80-86.
7.Farnone Sv, Chen WJ, Goldstein M, et al. Gender differences in age at onset of Schizophrenia. Br. J. Psychiat.. 1968:14:625-29.
8.Takei N. O’Callaghan E. Shatno P, et at Season at’ admission rates in the psychosis. Br. J. Psyehiat., 1992:161 :506-1I.
9.Takei N, Murray RM. Gender differenees of Schizophrenia in Seasonal admission in Scotland. Br. I. Psyehiat., 1993,162 272-73
10.Lewine RRJ. Gettder and Schizophrenia. In: Nabrallah I IA ed). Handbook of Schizophrenia vol. 3. The Netherlands Elsevier. 1988, pp. 379-97.
11.MeGlashan TH, Bardenstein KK. Gender difference in affective schizoaffeetive and Schizophrenic disorders. Schizophrenia Bulletin, 1990:16:319-26.
12.Bardenstein KK, McGlashan TH, Gender differences m affective, sehizoaffeetive and schizophrenic disorders. A review. Schizophrenia Research. 1990:3:159-72.
13.Test MA, Burke 55. Wallisch I.S. Gender differences of young adults with Schizophrenic disorders. Schizophrenia Bulletin, 1990:16:3 19-29.
14.Stusser E. Varma VK, Matuoo SK, ci al. l.ong term course of acute brief psychosis in a developing country. Br. I. Psychiat., 1998.173:226-30.
15.Ring N. Tatitam D. Motitague L. ci at. Gender differences in the incidence of definite schizophrenia and atypical psychosis - Focus on negative symptoms of schizophrenia. Acta Psyehiatr. Scand 1991 :84 489-96.
16.Foerster A, Lewis SW, Owen MJ, ci al. Pre-morbid personality in psychoses: effects of sex and diagnosis. Br. J Psychiatr.. 1991:158:171-76.

17.Childers SF.. Flarding CM. Gender, pre-morbid soeinl functioning and long icon outcome of DSM Ill Schizophrenics. Schizophrenia Bulletin. 1990;16:309-18.
18.Crow Ti, Done Di, Sacker A. Childhood precursors of psychosis as cities to its evolutionary origins. Fur. Arch. Psychiatry Cliii. Nenrosci., 1995:245:61­-69.
19.Goldstein JM, Santangelo SL. The role of gender in identifying sub-types ot Sehizophrenia: a latent class analytic approach. Schizophrenia Bulletin.1990; 16:263-75.
20.Goldstein iM, Faronc Sv, Chen Ni. ci al. Sex differences in the familial traasmission of Schizophrenia. Br. I. Psychiatr., 1990:156:810-26.
21.Seeman MV. The role of oestrogen in Sctiizophrenia. I Psvehiatry Neuroses, 1996;2 1: 123-27.
22.Hallonquist JD. Seetnan MV, I.ang M. et al, Variation in s mptom severity over the menstrual cycle of schizophrenic s It olog teal Psychiatry. 1993:33:207-9.
23.Riecher-Rossler A, liafner H. Stumbaum M. ci al, Can oestroidah modulate schizophrenic symptomatology? Schizophrenia Bulletin. 1994:20:203-14.
24.Tony EF. Taylor E, Bowler A, et al. Evident early brain changes in sub-groups of twins with Schizophrenia. Schizophrenia Research, 1991:4 -285.
25.Castle Di, Murray RM. The neurodevelopmental basis of sex difference in Schizophrenia. Psychological Medicine, 1991:21:565-75.
26.Marsh L. Pearlsoa GD, Richards SS. ci al Structural brain changes in Schizophrenia: MRI replication of a post-mortem study. Proceedings of International Congress on Sehizophrenia Research. Tuscon April, 1991 ;21-25.
27.Andreasen NC, Erhardt JC, Swayze VW, et al. MRI of the brain in Schizophrenia. Archives of Gen. Psychatry, 1990:47:35-44.
28. Castle Di, Abei K, Takei N, et al. Gender differences in Schizophrenia:
Hormonal effect or sub-types. Schizophrenia Bulletin, 1995;1 :1-12.
29.Kendell RE, Kemp 1W. Maternal influenza in the aetiology of schizophrenia. Arch, Gen. Psych., 1989:46:878-82.
30.Mcdnick SA, Machon RA, Hutuner MO. et at. Influenza and schizophrenia. Helsinki vs Edinburgh. Arch, Gen. Psych., 1990;47:875-76.
31.Takei N, Sham P, O’Challaghan 6, et at. Parental influenza and schizophrenia:
Is the effect confined to females? Amer. J. Psychiatr., 1994;15l:117-19.
32.Seeman MV. Gender differences in Schizophrenia. Canad. J, Psychiatr.,
1985:30:311-15.
33.Kopala LC, Fredrickson D. Good KP, et at. Symptoms in neuroleptie natve first episode Schizophrenia: response to Risperidone. Riot. Psychiat.,
1 996;39:296-98.
34.Hans GL, Glick GD, Clarkin JF, et al. Gender and Schizophrenia outcome A ci ideal trial of an in—patient family intervention. Schizophrenia Bulletin,
1990;16:277-92.
35.Goldstein JM. Geisdcr differences in the course of schizophrenia. Anser. J. Psychiatr 1958:145:684-89.
36.Novaro F, Van Os J, Jones P. es at. Explaining sex differences iti course and otttcome in the functional psychosis. Schizophrenia Research, 1996:21:161¬70.
37.Angermeyer MC, Kuhn L, Goldstein JM. Gender and the course of
Schizophrenia:    Differences us heated outcomes. Schizophrenia Bulletin,
1990:16:293-307.
38.Thara It, Hanvicna M, Joseph II, ci at. len year cottrse of schizophrenia. ‘the Madras longitudinal study. Acta. Psychiatrica. Scandinavica., 1994:90:326-36.
39.Gureji 0. Gender and Schizophrenia: age at onset and sown demographic attributes. Aeta. Psyehiatrica. Seandinavica. 1991:83:402-5.
40.Roder-Wamer U, Oliver  PJ, Pricbe S. Does Quality of Life ditier in schizophrenic women and men? An em pirical study. International Journal of Social Psychiatry, 1 997:43: 1 29-43.
41.Mnrthy GVS, Janakeramaiah N, Gangadhar BN, ct al Sex difference in age at onset of Schizophrenia: discrepant findings horn India, Acta. Psychiatric. Seanditiavia,, 1998;97:321-25.
42.Shankar R, Kansath S, Albeit-Joseph A. Gender differences in disability: A comparison of married patients with schizophrenia Schizophrenia Ret.,
1995;16:17-23.
43.Lindstrom 6, Knorring L. Symptoms in Schizophrenia Syndromes in relation to age, sex, duration of illness and number of previous hospitalisations. Acta Psychiatrica. Scandinaviea., 1994:89:274-78.
44.Fenning 5, Putnam K, Broinet EJ, ef al. Gender, pre-ntorbid characteristics and negative symptoms in Sclsizophretiia. Acta. Psycl iatricn. Scandinavica.,
995:92:13-77.
45.Kendler KS, Walsh t). Gender and Schizophrenia: resul ts of an epidemiologically - based family study Br. 3. Psychiatr.. 1995:167; 184-92.


News & Events

WHO/GOARN Request for technical assistance for Cholera Control in Northern Iraq

Request for assistance

WHO is requesting assistance from GOARN partners to identify the following cholera and diarrhoeal diseases expertise to support the Ministry of Health of Iraq in cholera risk assessment and immediate preparedness activities to improve the health outcomes of the Syrian refugees current living in camps in the Kurdistan region of Iraq.

  • two (2) epidemiologists
  • two (2) clinical management experts
  • one (1) environmental health expert (WATSAN)
  • one (1)laboratory expert

Duration

6 day mission starting 13 June 2014 (this excludes travel time).

Location

Northern Iraq (Kurdistan region).

Language requirements

All candidates must be fluent in English- written, spoken and comprehension. Fluency in Arabic is an asset. Knowledge, abilities and skills All candidates are expected to demonstrate the following

  • Ability to conceptualize and promote innovative strategies and policies.
  • Ability to communicate and write in a clear concise manner, and to develop effective guidelines.
  • Excellent negotiation and interpersonal skills complemented by ability to motivate and lead others and to promote consensus. Tact, discretion and diplomacy
  • Demonstrated ability for project appraisal, project management, monitoring and evaluation and project impact assessment.
  • Ability to work with host governments and their agents, INGOs and national NGOs an advantage.
  • Proven experience of managing a large workload and multiple priorities.
  • Ability to work in difficult conditions.

Support to the mission

WHO/GOARN will cover the travel and per diem (to cover daily expense in the field) expenses for the duration of their mission. GOARN missions do NOT offer salary, consultancy fees or any other form of remuneration.

WHO will provide appropriate logistics support for the field mission. Pre-deployment orientation/training may be required at WHO.

Partners offers of assistance

Partners are requested to reply with offers of assistance, together with CVs and details of the availability of staff for this mission by email to goarn@who.int latest by 30 May 2014. Details of all offers from partners and eventual deployments will be maintained on the GOARN SharePoint.

Operational Contacts

Mamunur Malik WHO EMRO malikm@who.int

William Perea WHO HQ pereaw@who.int

Patrick Drury GOARN druryp@who.int



News



Index



Supplement